Approval for human clinical trials for two made-in-India COVID-19 vaccine candidates - COVAXIN and ZyCov-D - marks the "beginning of the end" for the novel coronavirus pandemic that has infected over 1.12 crore people worldwide and left more than 5.3 lakh dead, the government said on Sunday.
from Videos https://ift.tt/3isv1Kx
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment